• Prontosan Antimicrobial Wound Irrigation Solution 350 ml Bottle
1 1

B. Braun

Prontosan Antimicrobial Wound Irrigation Solution 350 ml Bottle

Prontosan Antimicrobial Wound Irrigation Solution 350 ml Bottle

$28.00 SGD
$0.00 SGD $28.00 SGD
促销 售罄
结账时计算的运费。
Clinical Summary: Prontosan Wound Irrigation Solution by B. Braun is a sterile, ready-to-use antimicrobial wound cleanser containing 0.1% polyhexanide (PHMB) and 0.1% undecylenamidopropyl betaine. The dual-action formulation disrupts and removes wound biofilm through surfactant activity while providing broad-spectrum antimicrobial coverage against gram-positive and gram-negative bacteria, fungi, and yeast including MRSA and Pseudomonas aeruginosa. Indicated for cleansing, moistening, and decontamination of acute wounds, chronic wounds, and first- and second-degree burns.

Product Overview

Prontosan Wound Irrigation Solution is a colourless, odourless sterile solution developed by B. Braun Medical for the mechanical cleansing, moistening, and decontamination of acute and chronic wounds. The formulation combines purified water with 0.1% polyhexanide (polyhexamethylene biguanide, PHMB) — a broad-spectrum antimicrobial agent — and 0.1% undecylenamidopropyl betaine, a surfactant that lowers surface tension to facilitate penetration into wound biofilm matrices and disruption of bacterial colonies embedded within the wound bed.

The 350 ml bottle delivers wound irrigation at approximately 7 PSI when applied directly, providing selective mechanical debridement without cytotoxic effects on healthy granulation tissue. Prontosan is alcohol-free, pH-neutral, and preservative-free, making it suitable for sensitive skin and long-term use in chronic wound management protocols. The solution is compatible with a broad range of wound dressings including foams, alginates, hydrofibers, and gauze-based packing materials.

Specifications

Manufacturer B. Braun Medical AG (Germany)
Product Name Prontosan® Wound Irrigation Solution
REF / Catalogue 400441
Volume 350 ml
Active Agents 0.1% Polyhexanide (PHMB) + 0.1% Undecylenamidopropyl betaine
Composition Purified water, polyhexanide, betaine surfactant
pH Neutral
Sterility Sterile, single-use bottle
Latex Content Latex-free
Antimicrobial Spectrum Gram-positive, gram-negative bacteria, MRSA, Pseudomonas aeruginosa, VRE, fungi, yeast
Regulatory CE marked Class III Medical Device per EU MDR 2017/745; FDA 510(k) cleared (K101882); ISO 13485 certified manufacturing
Packaging 350 ml squeeze bottle, 10 bottles per carton

Clinical Indications

  • Irrigation and decontamination of acute traumatic wounds, post-surgical incision sites, and skin graft donor areas
  • Cleansing and biofilm management in chronic wounds including venous leg ulcers, diabetic foot ulcers, and pressure injuries (Stage II–IV)
  • Wound bed preparation and maintenance debridement in wounds with fibrinous slough or suspected biofilm
  • Cleansing of first- and second-degree burn injuries prior to dressing application
  • Moistening of wound pads and dressings to facilitate atraumatic removal
  • Adjunctive irrigation in Negative Pressure Wound Therapy (NPWT) and instillation protocols

Frequently Asked Questions

Q: What is the mechanism of action of Prontosan against wound biofilm?

A: Prontosan employs a dual-action approach. The betaine surfactant lowers surface tension to penetrate and mechanically disrupt the extracellular polymeric substance (EPS) matrix that protects bacterial biofilm. Once disrupted, the polyhexanide (PHMB) component exerts broad-spectrum antimicrobial activity against planktonic and sessile bacteria. This synergistic mechanism is consistent with the International Wound Infection Institute (IWII) recommendations for biofilm-based wound management.

Q: How does Prontosan compare to normal saline for wound irrigation?

A: While 0.9% sodium chloride remains appropriate for basic wound rinsing, it lacks antimicrobial and surfactant properties. Prontosan provides active biofilm disruption and sustained antimicrobial coverage. Multiple randomised controlled trials have demonstrated superior wound bed preparation and reduced bacterial burden compared to saline alone, particularly in chronic wounds with confirmed or suspected biofilm.

Q: Is Prontosan safe for long-term use on chronic wounds?

A: Yes. Prontosan is alcohol-free, pH-neutral, and has demonstrated favourable tissue compatibility in clinical studies. The low concentration of PHMB (0.1%) provides antimicrobial efficacy without cytotoxicity to fibroblasts and keratinocytes, supporting its use in extended treatment protocols for chronic wound management.

Q: Can Prontosan be used on infected wounds or wounds with exposed bone or tendon?

A: Prontosan is indicated for wound cleansing and decontamination. For wounds with clinical signs of infection, systemic antimicrobial therapy should be considered as per institutional protocols. Use on wounds with exposed deep structures should follow clinician assessment. Consult the B. Braun instructions for use for specific contraindications.

Q: Is Prontosan Wound Irrigation Solution available in Singapore?

A: Yes. Prontosan is available through EMIS (Essential Medical International Supplies Pte Ltd) in Singapore. As a CE Class III and FDA 510(k)-cleared medical device, it is registered under the Health Sciences Authority (HSA) regulatory framework for distribution to healthcare facilities, wound care clinics, and home-care providers across Singapore.

查看完整详细信息